Toni Manzano

Aizon
CSO & Co-Founder
Toni Manzano is co-founder and CSO of Aizon, a cloud company that provides big data and AI SaaS platform for the Biotech and Pharma industry. Since 1996 he has led software projects for international pharmaceutical companies covering the entire production process and supply chain (R&D, clinical trials, production, laboratory, quality assurance, warehousing and logistics). In pharma manufacturing he was specifically dedicated to biotech processes, always improving critical operations. He has also led projects implementing solutions based on the 3 ICH (Q8, Q9 and Q10) and executing audit, qualification and validation tasks. Toni is member of the AI initiative for AFDO and collaborator with the UN in AI subjects. Toni is in the scientific committee of the PDA Europe supporting annual events for the innovation and technology in pharma.
He worked as a researcher at the University of Barcelona as physicist and he teaches Big Data and Artificial Intelligence subjects related with the Pharma Industry in specific postgraduate courses at the University (UAB, OBS and URV). He has written numerous articles in the Pharma field and holds a dozen international patents related to the encryption, transmission, storage and processing of large volumes of data for regulated environments in the cloud. Toni is Physicist, Master in Information and Knowledge Society and post graduated in quality systems for manufacturing and research pharmaceutical processes.

Related Articles

Figure 3: Adoption time in years experienced by nonpharmaceutical and pharmaceutical industries since the technologies were invented/discovered.
Features
Measuring Pharma’s Adoption of Industry 4.0

With the rise of new technologies and predictive analytics capable of handling the huge amounts of data within and across existing information systems, Industry 4.0 has been thriving in many sectors, such as industrial automation, financial technology, retail, and semiconductors. But the health sector in general,Singh, P., S. N. Singh, and L. Ram. “Health 4.0: Role of Health...

AI’s Promise for ATMPS - C0ver Image
Features
AI’s Promise for ATMPs

Industry 4.0 applications in biopharma involve the complete spectrum of data science throughout the entire product life cycle of many disparate entity types. Tools such as digitalization, modern data science, and the industrial internet of things (IIoT) exist now, and examples from other industries such as Siri and Alexa, face identification, and self-driving cars can guide their...